The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
i mean we in our trial we were our funding body which is like the uk state didn't want us to include people on ssris but actually most of the studies the depression studies people are still on them and there's no interaction so it's not like some of the other novel substances like psilocybin where you'd because they're it's working in a completely different way in the brain so yeah
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.